Miebomian Gland and Ocular Surface Disease
Over the past 15 years, research has revealed that the leading cause of eye discomfort for over 86% of patients with dry eye is MGD.1 MGD is a disease best detected in its earliest stages and then managed to limit progression.
MGD occurs when the protective oil that normally flows from the eyelid (meibomian) glands slows or stops. Over time, blockage and structural damage of the glands occurs. The oil acts as the front line of protection for the tears and lubricates the surface of the eyes when you blink. When these glands are not healthy, it causes the tear film to rapidly evaporate, leaving the eye’s surface exposed. This exposure can cause discomfort that increases over time and impacts quality of vision. This can result in irritating dry eye symptoms. A routine check for MGD as a part of any eye exam is recommended.
GOC is proud to announce that we are now offering the latest technology in the analysis of MGD and Ocular Surface Disease analysis and treatment. The LipiView and LipiFlow system from Tear Science!
Eye care professionals are seeing MGD present in people of all ages. Modern lifestyles, dry environments and excessive use of display technologies can lead to infrequent blinking, called “evaporative stress.” The lack of blinking creates a demand for more lubrication on the eye, stimulating more oil production. Over time, this leads to thickening of the oil, blockage of the gland opening and shutdown of oil production in the gland.
If you have MGD, there are many factors that can increase the likelihood of developing dry eye symptoms.
The only treatment that is FDA cleared to treat the underlying cause of Dry Eye and MGD is available at our Clinic! Give us a call today to start enjoying relief from your dry eye symptoms!